The variety of mouse models detailed above has brought a plethora of knowledge regarding TDP‐43 function and potential therapeutic avenues that can be explored, such as utilisation of oxidation resistance 1 protein (Oxr1) to ameliorate the neuromuscular phenotype of ALS (Williamson et al., 2019). This evidence concerns the gene OXR1 and amyotrophic lateral sclerosis.